BAK1 and acute promyelocytic leukemia: In acute promyelocytic leukemia, miR-125b was found differentially expressed, promoting the proliferation of leukemic cells, and inhibiting cellular apoptosis by regulating the expression of the tumor suppressor BCL2-antagonista/killer1 (Bak1) [47].